Evidence map›Paper›PMID 23137658›Full record

ReviewBiochimica et biophysica acta2013

Platelet-derived growth factors and their receptors: structural and functional perspectives.

Po-Han Chen, Xiaoyan Chen, Xiaolin He

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 1 synthesis or guideline pooled it, 230 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Roles of PDGF/PDGFR signaling in various organs.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Review

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Po-Han ChenDepartment of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Searle 8-417, 303 East Chicago Avenue, Chicago, IL 60611, USA.
Xiaoyan Chen
Xiaolin He
Northwestern University · US

Funding

Molecular Biophysics Training Program at Northwestern UniversityT32GM008382 · NIGMS · NORTHWESTERN UNIVERSITY · PI RADHAKRISHNAN, ISHWAR · 1990 to 2020
$4.3M
Structural biology of oncogenic receptor tyrosine kinasesR01GM078055 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HE, XIAOLIN · 2006 to 2010
$1.4M
Structural Mechanisms in Semaphorin SignalingR01GM098259 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HE, XIAOLIN · 2011 to 2014
$1.1M
NIGMS NIH HHS 5R01GM098259NIGMS NIH HHS R01 GM078055NIGMS NIH HHS R01 GM098259NIGMS NIH HHS T32 GM008382
6 · The paper itself

Abstract

The four types of platelet-derived growth factors (PDGFs) and the two types of PDGF receptors (PDGFRs, which belong to class III receptor tyrosine kinases) have important functions in the development of connective tissue cells. Recent structural studies have revealed novel mechanisms of PDGFs in propeptide loading and receptor recognition/activation. The detailed structural understanding of PDGF-PDGFR signaling has provided a template that can aid therapeutic intervention to counteract the aberrant signaling of this normally silent pathway, especially in proliferative diseases such as cancer. This review summarizes the advances in the PDGF system with a focus on relating the structural and functional understandings, and discusses the basic aspects of PDGFs and PDGFRs, the mechanisms of activation, and the insights into the therapeutic antagonism of PDGFRs. This article is part of a Special Issue entitled: Emerging recognition and activation mechanisms of receptor tyrosine kinases.

Indexed as

Blood PlateletsConnective TissueConnective Tissue CellsGene Expression RegulationHumansModels, MolecularPlatelet-Derived Growth FactorProtein BindingProtein IsoformsProtein PrecursorsReceptors, Platelet-Derived Growth FactorSignal TransductionPlatelet-Derived Growth FactorProtein IsoformsProtein PrecursorsReceptors, Platelet-Derived Growth FactorGrowth factorPropeptide recognitionReceptor activationReceptor tyrosine kinaseSignal transduction

Identifiers

PMID23137658
PMCPMC3612563
OpenAlexW2040051713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.